BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/4/2021 7:56:20 AM | Browse: 807 | Download: 2096
 |
Received |
|
2021-01-28 23:24 |
|
Peer-Review Started |
|
2021-01-28 23:29 |
|
First Decision by Editorial Office Director |
|
2021-03-06 06:38 |
|
Return for Revision |
|
2021-03-06 06:38 |
|
Revised |
|
2021-03-20 12:27 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-07-13 03:33 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-07-13 08:08 |
|
Articles in Press |
|
2021-07-13 08:08 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-07-30 08:07 |
|
Publish the Manuscript Online |
|
2021-08-04 07:56 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Brittany B Dennis, Leen Naji, Yasmin Jajarmi, Aijaz Ahmed and Donghee Kim |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Donghee Kim, MD, PhD, N/A, N/A, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, 300 Pasteur Drive, Palo Alto, CA 94034, United States. dhkimmd@stanford.edu |
| Key Words |
Hepatitis C virus; Direct-acting antivirals; Global health; Liver transplantation; People who inject drugs; Liver cirrhosis |
| Core Tip |
Hepatitis C virus (HCV) is a global health concern associated with significant morbidity and mortality. The introduction of well-tolerated oral direct-acting antiviral agents in late 2013 has revolutionized HCV management with over 90% cure rates. Equitable access to these agents remains an important issue, given that countries with the greatest burden of disease have the least access to curative therapies. Here we provide a literature review of HCV, changes in epidemiologic trends, current therapies, and highlight inequities in the burden of disease and access to treatment. |
| Publish Date |
2021-08-04 07:56 |
| Citation |
Dennis BB, Naji L, Jajarmi Y, Ahmed A, Kim D. New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years. World J Gastroenterol 2021; 27(29): 4818-4830 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i29/4818.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i29.4818 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
